Lydia Abasolo1, Jose Ivorra-Cortes2, Leticia Leon3, Juan A Jover3, Benjamin Fernandez-Gutierrez3, Luis Rodriguez-Rodriguez3. 1. Rheumatology Department and Health Research Institute (IDISSC), Hospital Clínico San Carlos, Calle Prof. MArtín Lagos s/n, Madrid 28040, Spain. Electronic address: lydia.abasolo@salud.madrid.org. 2. Rheumatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain. 3. Rheumatology Department and Health Research Institute (IDISSC), Hospital Clínico San Carlos, Calle Prof. MArtín Lagos s/n, Madrid 28040, Spain.
Abstract
OBJECTIVES: To describe the mortality rate (MR) and standardized MR (SMR) of an incident cohort of rheumatoid arthritis (RA) patients followed up for 20 years, and to analyze the influence on morality risk of different demographic and clinical variables, including radiographic joint damage. METHODS: Retrospective longitudinal study that included 2271 RA patients attending the rheumatology outpatient clinic of the Hospital Clínico San Carlos (Madrid, Spain), enrolled from January 1994 to February 2013 and followed up from RA diagnosis to patients׳ death or September 2013. Disability and disease activity were measured as the averaged value of the Heath Assessment Questionnaire and the erythrocyte sedimentation rate, respectively, of the first 2 years after RA diagnosis. Radiographic joint damage of hands and wrists was assessed with the Sharp/van der Heijde score. Indirect SMRs with a 95% of confidence interval (95% CI) were calculated. Cox bivariate and multivariate regression models were performed to assess risk factors for death. RESULTS: A total of 431 patients died (19%) during the observation time (18,482 person-years), resulting in a MR of 23 subjects per 1000 patient-years [95% CI: 21-26]. SMR was 1.89 (1.72-2.08). In the multivariate analysis, men, older age at diagnosis, the presence of rheumatoid factor, higher number of hospital admissions, greater disease activity, and greater radiographic joint damage were independently associated with greater mortality risk. CONCLUSIONS: RA patients have an excess mortality compared with the general population. Radiological joint damage and early disease activity are independent mortality risk factors. A tighter control at early stages may be necessary to reduce mortality.
OBJECTIVES: To describe the mortality rate (MR) and standardized MR (SMR) of an incident cohort of rheumatoid arthritis (RA) patients followed up for 20 years, and to analyze the influence on morality risk of different demographic and clinical variables, including radiographic joint damage. METHODS: Retrospective longitudinal study that included 2271 RApatients attending the rheumatology outpatient clinic of the Hospital Clínico San Carlos (Madrid, Spain), enrolled from January 1994 to February 2013 and followed up from RA diagnosis to patients׳ death or September 2013. Disability and disease activity were measured as the averaged value of the Heath Assessment Questionnaire and the erythrocyte sedimentation rate, respectively, of the first 2 years after RA diagnosis. Radiographic joint damage of hands and wrists was assessed with the Sharp/van der Heijde score. Indirect SMRs with a 95% of confidence interval (95% CI) were calculated. Cox bivariate and multivariate regression models were performed to assess risk factors for death. RESULTS: A total of 431 patients died (19%) during the observation time (18,482 person-years), resulting in a MR of 23 subjects per 1000 patient-years [95% CI: 21-26]. SMR was 1.89 (1.72-2.08). In the multivariate analysis, men, older age at diagnosis, the presence of rheumatoid factor, higher number of hospital admissions, greater disease activity, and greater radiographic joint damage were independently associated with greater mortality risk. CONCLUSIONS:RApatients have an excess mortality compared with the general population. Radiological joint damage and early disease activity are independent mortality risk factors. A tighter control at early stages may be necessary to reduce mortality.
Authors: Martin Feuchtenberger; Axel Philipp Nigg; Michael Rupert Kraus; Arne Schäfer Journal: Clin Med Insights Arthritis Musculoskelet Disord Date: 2016-10-02
Authors: Katja Heinimann; Johannes von Kempis; Rafael Sauter; Michael Schiff; Tuulikki Sokka-Isler; Hendrik Schulze-Koops; Rüdiger Müller Journal: J Clin Med Date: 2018-03-13 Impact factor: 4.241
Authors: Jolanta Dadonienė; Greta Charukevič; Gabija Jasionytė; Karolina Staškuvienė; Dalia Miltinienė Journal: Int J Environ Res Public Health Date: 2021-11-24 Impact factor: 3.390
Authors: Maria A Nieto; Maria J Rodriguez-Nieto; Olga Sanchez-Pernaute; Fredeswinda Romero-Bueno; Leticia Leon; Cristina Vadillo; Dalifer D Freites-Nuñez; Juan A Jover; Jose L Álvarez-Sala; Lydia Abasolo Journal: BMC Pulm Med Date: 2021-06-30 Impact factor: 3.317
Authors: Cristina Regueiro; Luis Rodriguez-Rodriguez; Raquel Lopez-Mejias; Laura Nuño; Ana Triguero-Martinez; Eva Perez-Pampin; Alfonso Corrales; Alejandro Villalba; Yolanda Lopez-Golan; Lydia Abasolo; Sara Remuzgo-Martínez; Ana M Ortiz; Eva Herranz; Ana Martínez-Feito; Carmen Conde; Antonio Mera-Varela; Alejandro Balsa; Isidoro Gonzalez-Alvaro; Miguel Ángel González-Gay; Benjamín Fernandez-Gutierrez; Antonio Gonzalez Journal: Sci Rep Date: 2020-02-25 Impact factor: 4.379